Penserra Capital Management’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15
| Closed | -$1K | – | 1143 |
|
|
2026
Q1 | $1K | Hold |
15
| – | – | ﹤0.01% | 1049 |
|
|
2025
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 1026 |
|
|
2025
Q3 | $1K | Sell |
15
-6
| -29% | -$398 | ﹤0.01% | 997 |
|
|
2025
Q2 | $1K | Sell |
21
-13,191
| -100% | -$791K | ﹤0.01% | 993 |
|
|
2025
Q1 | $815K | Buy |
13,212
+12,603
| +2,069% | +$835K | 0.01% | 501 |
|
|
2024
Q4 | $43K | Buy |
609
+588
| +2,800% | +$45.9K | ﹤0.01% | 945 |
|
|
2024
Q3 | $1K | Buy |
21
+3
| +17% | +$240 | ﹤0.01% | 1073 |
|
|
2024
Q2 | $1K | Hold |
18
| – | – | ﹤0.01% | 1225 |
|
|
2024
Q1 | $1K | Sell |
18
-1,117
| -98% | -$83.1K | ﹤0.01% | 1195 |
|
|
2023
Q4 | $80K | Sell |
1,135
-238
| -17% | -$16.6K | ﹤0.01% | 926 |
|
|
2023
Q3 | $94K | Sell |
1,373
-224
| -14% | -$16.9K | ﹤0.01% | 902 |
|
|
2023
Q2 | $129K | Buy |
1,597
+1,583
| +11,307% | +$129K | ﹤0.01% | 897 |
|
|
2023
Q1 | $1K | Sell |
14
-38,368
| -100% | -$3.09M | ﹤0.01% | 1056 |
|
|
2022
Q4 | $2.87M | Buy |
+38,382
| New | +$2.73M | 0.06% | 302 |
|
|
2021
Q1 | – | Sell |
-27,852
| Closed | -$2.03M | – | 1133 |
|
|
2020
Q4 | $2.03M | Buy |
27,852
+24,357
| +697% | +$1.72M | 0.05% | 258 |
|
|
2020
Q3 | $232K | Buy |
+3,495
| New | +$221K | 0.01% | 420 |
|
|
2020
Q2 | – | Sell |
-2,295
| Closed | -$119K | – | 853 |
|
|
2020
Q1 | $119K | Buy |
2,295
+503
| +28% | +$23.9K | 0.01% | 522 |
|
|
2019
Q4 | $96K | Buy |
+1,792
| New | +$89.2K | 0.01% | 610 |
|
Other funds holding HOLX
Penserra Capital Management's HOLX Position: Q2 2026 in Review
Penserra Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 15 shares — an estimated $1K sold.
Penserra Capital Management first reported a position in HOLX in Q4 2019 and held it in 18 quarters. The position peaked at $2.87M in Q4 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Penserra Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Penserra Capital Management sold 15 Hologic shares in Q2 2026, an estimated $1K.
- Penserra Capital Management first reported a position in Hologic in Q4 2019 and held it in 18 quarters.
- Penserra Capital Management's Hologic position peaked at $2.87M in Q4 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.